Tuesday, May 19, 2020 4:51:27 PM
perhaps ...
-=--
however we know that they filed an 8-k and stated on May 1,2020
*
Company outstanding on April 30, 2020 was 109,553,548
===
Right now in their Security Disclosure as of May 8, 2020 the outstanding
shares O/S went up to 120, 587, 358
---
So in essence they added 11,000,000 shares it would seem to the O/S , but the A/S remained the same.
---
Lets see that filing and what everelse comes out ... Cliff and ITOX team have a strategy and hopefully they share some of that shortly .. all good with this Mgt Team and Advisors.... their backgrounds, Networking and being Global in nature in his background .... I mean look at his linked in file, he has Global Experience
---
https://www.linkedin.com/in/cliff-emmons/
--
Experience
IIoT-Oxys
CEO
Company NameIIoT-Oxys
Dates EmployedJun 2018 – Present
Employment Duration2 yrs
LocationGreater Boston Area
Leading IIoT-Oxys, a company at the intersection of IIoT, AI/ ML, and Healthcare Operations, to enable Pharma, Biotech, and Medical Device manufacturing organizations in gaining actionable insights from their operations-generated data. Leveraging IIoT-Oxys’s Edge Computing hardware and algorithms to produce data driven decisions for its customers to achieve Industry 4.0 standards, and the next wave of best-in-class quality and productivity gains.
Accelerated Healthcare Innovations, LLC
Founder, Medical Device Senior Leader
Company NameAccelerated Healthcare Innovations, LLC
Dates Employed2017 – Present
Employment Duration3 yrs
LocationGreater Boston Area
Fostering innovation in the Boston-Cambridge area, and innovation ecosystems worldwide by:
- Scouting technology and start-ups for multinational medical device companies
- Mentoring and advocating promising technology and clinical researchers to launch start-ups
- Advising and sponsoring promising start-ups through journey from seed funding to acquisition
- Connecting elements of the Boston-Cambridge innovation ecosystem for its continued success
…
see more
Medtronic
Company NameMedtronic
Total Duration4 yrs
TitleVice President, R&D India & Extended Emerging Markets
Dates Employed2015 – 2017
Employment Duration2 yrs
LocationMansfield, MA, USA
Reported to the President of the Patient Monitoring & Recovery (PMR) business unit, chaired the PMR R&D Council, instituted operating principles resulting in visibility and accountabilty of R&D projects, and unlocked funding for critical new projects.
Led the Medtronic Engineering & Innovation Center (MEIC) in Hyderabad, India for the Minimally Invasive Therapies Group (formerly Covidien), with over 200 engineers. Continued responsibility for the extended emerging markets R&D teams. Transformed MEIC from a pure Engineering Services team to a full-fledged R&D center, including launching the center's first PMA (Class 3) device, and bringing team morale to an all-time high.
…
see more
TitleVice President Extended R&D MITG
Dates Employed2013 – 2017
Employment Duration4 yrs
LocationMansfield, MA
Created and led extended R&D teams collocated at Medtronic Innovation Centers (MICs) based in Seoul & Osong, South Korea; Istanbul, Turkey; and Sao Paulo, Brazil. Designed, built, equipped, and commissioned all three R&D labs, elevating training facilities to innovation centers. Envisioned group charter, hired, trained, and coached the leaders and staff - creating effective "extended" team members for global development teams. Through deep "voice of customer" skills and technology scouting, developed a robust "bullpen" of projects for the global and localized product portfolios.
…
see more
Covidien
Company NameCovidien
Total Duration8 yrs
TitleVice President, Tailored Products - Emerging Markets
Dates Employed2010 – 2013
Employment Duration3 yrs
LocationSingapore
Envisioned and established a greenfield R&D center in Shanghai, specifically created for localized ("tailored") products for the emerging markets. Vetted and hired the initial local (Chinese National) director-level leaders. Rapidly led technology transfer from global R&D to nascent China teams. Worked with CTO to hire and partner with a Chinese National (repatriated) as VP China R&D of the Shanghai site. Launched the first products from center within first year of operation. Established the initial product portfolio that resulted in more than a dozen products launched within five years with multi-million USD annual revenue growing at double digit rates.
…
see more
TitleDirector, Engineering Services
Dates Employed2005 – 2010
Employment Duration5 yrs
LocationNorth Haven, CT
Led a multi-disciplined team using internal and external resources to provide Industrial Design, Rapid Prototyping, and Pilot Tooling services to global development teams. Leveraged Indian Engineering Service Providers (ESPs) to augment capabilities of global R&D teams, earning the inagural Covidien Emerging Markets Innovation Award. Led a cross-functional team that developed the first "local for local" product for the emerging markets leveraging Indian ESPs. Partnered with an internal team and McKinsey & Co. consultants to secure BOD approved funding to establish Covidien's China R&D and India engineering centers.
…
see more
Education
University of Connecticut
University of Connecticut
Degree NameBachelor of Science (B.S.)Field Of StudyMechanical Engineering
University of Bridgeport
University of Bridgeport
Degree NameMaster of Science (M.S.)Field Of StudyManagement Engineering
Designed to be an "MBA" for technical leaders, emphasizing technology a competitive advantage for entrepreneurial enterprise creation.
University of New Haven
University of New Haven
Degree NameBachelor of Science (B.S.)Field Of StudyElectrical EngineeringGradeCum Laude
==
Licenses & Certifications
MIT Sloan School of Management
Strategy & Innovation Executive Certificate
Issuing authorityMIT Sloan School of Management
Issued date and, if applicable, expiration date of the certification or licenseIssued Dec 2008No Expiration Date
-=--
however we know that they filed an 8-k and stated on May 1,2020
*
Company outstanding on April 30, 2020 was 109,553,548
===
Right now in their Security Disclosure as of May 8, 2020 the outstanding
shares O/S went up to 120, 587, 358
---
So in essence they added 11,000,000 shares it would seem to the O/S , but the A/S remained the same.
---
Lets see that filing and what everelse comes out ... Cliff and ITOX team have a strategy and hopefully they share some of that shortly .. all good with this Mgt Team and Advisors.... their backgrounds, Networking and being Global in nature in his background .... I mean look at his linked in file, he has Global Experience
---
https://www.linkedin.com/in/cliff-emmons/
--
Experience
IIoT-Oxys
CEO
Company NameIIoT-Oxys
Dates EmployedJun 2018 – Present
Employment Duration2 yrs
LocationGreater Boston Area
Leading IIoT-Oxys, a company at the intersection of IIoT, AI/ ML, and Healthcare Operations, to enable Pharma, Biotech, and Medical Device manufacturing organizations in gaining actionable insights from their operations-generated data. Leveraging IIoT-Oxys’s Edge Computing hardware and algorithms to produce data driven decisions for its customers to achieve Industry 4.0 standards, and the next wave of best-in-class quality and productivity gains.
Accelerated Healthcare Innovations, LLC
Founder, Medical Device Senior Leader
Company NameAccelerated Healthcare Innovations, LLC
Dates Employed2017 – Present
Employment Duration3 yrs
LocationGreater Boston Area
Fostering innovation in the Boston-Cambridge area, and innovation ecosystems worldwide by:
- Scouting technology and start-ups for multinational medical device companies
- Mentoring and advocating promising technology and clinical researchers to launch start-ups
- Advising and sponsoring promising start-ups through journey from seed funding to acquisition
- Connecting elements of the Boston-Cambridge innovation ecosystem for its continued success
…
see more
Medtronic
Company NameMedtronic
Total Duration4 yrs
TitleVice President, R&D India & Extended Emerging Markets
Dates Employed2015 – 2017
Employment Duration2 yrs
LocationMansfield, MA, USA
Reported to the President of the Patient Monitoring & Recovery (PMR) business unit, chaired the PMR R&D Council, instituted operating principles resulting in visibility and accountabilty of R&D projects, and unlocked funding for critical new projects.
Led the Medtronic Engineering & Innovation Center (MEIC) in Hyderabad, India for the Minimally Invasive Therapies Group (formerly Covidien), with over 200 engineers. Continued responsibility for the extended emerging markets R&D teams. Transformed MEIC from a pure Engineering Services team to a full-fledged R&D center, including launching the center's first PMA (Class 3) device, and bringing team morale to an all-time high.
…
see more
TitleVice President Extended R&D MITG
Dates Employed2013 – 2017
Employment Duration4 yrs
LocationMansfield, MA
Created and led extended R&D teams collocated at Medtronic Innovation Centers (MICs) based in Seoul & Osong, South Korea; Istanbul, Turkey; and Sao Paulo, Brazil. Designed, built, equipped, and commissioned all three R&D labs, elevating training facilities to innovation centers. Envisioned group charter, hired, trained, and coached the leaders and staff - creating effective "extended" team members for global development teams. Through deep "voice of customer" skills and technology scouting, developed a robust "bullpen" of projects for the global and localized product portfolios.
…
see more
Covidien
Company NameCovidien
Total Duration8 yrs
TitleVice President, Tailored Products - Emerging Markets
Dates Employed2010 – 2013
Employment Duration3 yrs
LocationSingapore
Envisioned and established a greenfield R&D center in Shanghai, specifically created for localized ("tailored") products for the emerging markets. Vetted and hired the initial local (Chinese National) director-level leaders. Rapidly led technology transfer from global R&D to nascent China teams. Worked with CTO to hire and partner with a Chinese National (repatriated) as VP China R&D of the Shanghai site. Launched the first products from center within first year of operation. Established the initial product portfolio that resulted in more than a dozen products launched within five years with multi-million USD annual revenue growing at double digit rates.
…
see more
TitleDirector, Engineering Services
Dates Employed2005 – 2010
Employment Duration5 yrs
LocationNorth Haven, CT
Led a multi-disciplined team using internal and external resources to provide Industrial Design, Rapid Prototyping, and Pilot Tooling services to global development teams. Leveraged Indian Engineering Service Providers (ESPs) to augment capabilities of global R&D teams, earning the inagural Covidien Emerging Markets Innovation Award. Led a cross-functional team that developed the first "local for local" product for the emerging markets leveraging Indian ESPs. Partnered with an internal team and McKinsey & Co. consultants to secure BOD approved funding to establish Covidien's China R&D and India engineering centers.
…
see more
Education
University of Connecticut
University of Connecticut
Degree NameBachelor of Science (B.S.)Field Of StudyMechanical Engineering
University of Bridgeport
University of Bridgeport
Degree NameMaster of Science (M.S.)Field Of StudyManagement Engineering
Designed to be an "MBA" for technical leaders, emphasizing technology a competitive advantage for entrepreneurial enterprise creation.
University of New Haven
University of New Haven
Degree NameBachelor of Science (B.S.)Field Of StudyElectrical EngineeringGradeCum Laude
==
Licenses & Certifications
MIT Sloan School of Management
Strategy & Innovation Executive Certificate
Issuing authorityMIT Sloan School of Management
Issued date and, if applicable, expiration date of the certification or licenseIssued Dec 2008No Expiration Date
TIME is an ILLUSION
---
TIMING is an actual ART
Recent ITOX News
- Form 8-K - Current report • Edgar (US Regulatory) • 04/20/2026 08:58:02 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 04/15/2026 05:46:46 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 04/14/2026 08:01:18 PM
- Form NT 10-K - Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405 • Edgar (US Regulatory) • 03/31/2026 04:06:14 PM
- Form D - Notice of Exempt Offering of Securities • Edgar (US Regulatory) • 03/23/2026 09:10:59 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/12/2026 06:59:20 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 12/12/2025 07:34:44 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/03/2025 08:31:20 PM
- Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB • Edgar (US Regulatory) • 11/14/2025 03:59:40 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/10/2025 08:26:24 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/04/2025 05:43:15 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 09/19/2025 08:49:35 PM
- Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB • Edgar (US Regulatory) • 08/14/2025 06:46:48 PM
- Form DEF 14C - Other definitive information statements • Edgar (US Regulatory) • 08/12/2025 05:27:32 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/07/2025 02:28:56 PM
- Form PRE 14C - Other preliminary information statements • Edgar (US Regulatory) • 08/01/2025 06:40:47 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/01/2025 06:18:05 PM
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 04/30/2025 05:47:59 PM
